B

Beta Bionics Inc
NASDAQ:BBNX

Watchlist Manager
Beta Bionics Inc
NASDAQ:BBNX
Watchlist
Price: 11.14 USD 0.81% Market Closed
Market Cap: 482.9m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+2%
Revenue
Forecast
-13%
Operating Income
Forecast
-66%
Net Income
Forecast
N/A

Wall Street
Price Targets

BBNX Price Targets Summary
Beta Bionics Inc

Wall Street analysts forecast BBNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BBNX is 26.23 USD with a low forecast of 18.18 USD and a high forecast of 31.5 USD.

BBNX Lowest Forecast
Wall Street Target
18.18 USD
63% Upside
BBNX Average Forecast
Wall Street Target
26.23 USD
135% Upside
BBNX Highest Forecast
Wall Street Target
31.5 USD
183% Upside
Lowest
Price Target
18.18 USD
63% Upside
Average
Price Target
26.23 USD
135% Upside
Highest
Price Target
31.5 USD
183% Upside
Beta Bionics Inc Competitors:
Price Targets
688580
Nanjing Vishee Medical Technology Co Ltd
27% Downside
S
SUS
Surgical Science Sweden AB
42% Upside
MEDX
Medmix Ltd
87% Upside
SYK
Stryker Corp
16% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
27% Downside
S
SUS
Surgical Science Sweden AB
42% Upside
MEDX
Medmix Ltd
87% Upside
SYK
Stryker Corp
16% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
31% Downside
P
PRCT
Procept Biorobotics Corp
78% Upside
300482
Guangzhou Wondfo Biotech Co Ltd
34% Upside
EW
Edwards Lifesciences Corp
8% Upside

Revenue
Forecast

Revenue Estimate
Beta Bionics Inc

For the last 1 year the compound annual growth rate for Beta Bionics Inc's revenue is 443%. The projected CAGR for the next 3 years is 33%.

443%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Beta Bionics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Beta Bionics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BBNX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BBNX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BBNX stock valuation using valuation multiples.
Wall Street Estimates
BBNX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BBNX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BBNX's stock price target?
Price Target
26.23 USD

According to Wall Street analysts, the average 1-year price target for BBNX is 26.23 USD with a low forecast of 18.18 USD and a high forecast of 31.5 USD.

What is Beta Bionics Inc's Revenue forecast?
Projected CAGR
33%

For the last 1 year the compound annual growth rate for Beta Bionics Inc's revenue is 443%. The projected CAGR for the next 3 years is 33%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.